David Porter is an Oncology physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce St
15 Penn Tower
Philadelphia, PA 19104
Telephone
215-662-3914Registry record last updated 23 Mar 2011.
Clinical trials
- Prevalence of Flexor Hallucis Longus Tears, Associated Os Trigonum Excision, and Return to Play
Sponsor: Forte Sports Medicine and Orthopedics
- A Universal Eye Drop Adherence Monitor to Measure and Improve Adherence to Ocular Medications
Sponsor: Universal Adherence LLC
- IFN-DLI for Relapsed Acute Leukemia After Allo-SCT
Sponsor: Abramson Cancer Center at Penn Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kite Pharma, Inc.Program year202510 payments$10,673openpaymentsdata.cms.gov ↗
- Incyte CorporationProgram year20259 payments
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
5 NIH research awards on record, funded 1996–2021 per NIH RePORTER. The latest:
- Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.
University of Pennsylvania
FY2021$415,924P01CA214278 - Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.
University of Pennsylvania
FY2020$340,461P01CA214278 - Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.
University of Pennsylvania
FY2019$427,021P01CA214278
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”